相关实验视频
Updated: May 7, 2025

08:48
A Rat Model of EcoHIV Brain Infection
Published on: January 21, 2021
3.1K
CROI 2024:艾滋病毒感染者的神经精神疾病并发症
Michael J Corley1, Scott L Letendre2, Sam Nightingale3
1Weill Cornell Medicine, New York, New York, USA.
Topics in antiviral medicine
|January 2, 2025
概括
新的研究突出了艾滋病毒感染者的神经心理并发症,包括大脑炎症和衰老风险. 调查结果涵盖全球数据,艾滋病毒的持续性,以及神经性艾滋病毒的潜在治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 人类免疫缺陷病毒 (HIV) 感染者的神经精神疾病并发症是显著的.
- 了解这些并发症对于改善患者的治疗结果和生活质量至关重要.
研究的目的:
- 在2024年关于逆转录病毒和机会性感染的会议上提出的关于艾滋病毒的神经精神病学并发症的关键发现的总结.
- 突出神经艾滋病毒领域的新研究方向.
主要方法:
- 在一个主要的传染病会议上提出的新证据的审查.
- 综合与艾滋病毒持久性,衰老,病原和治疗相关的发现.
主要成果:
- 在抑制性治疗期间,在中枢神经系统中存在活跃的HIV RNA转录的证据.
- 神经精神问题与动脉炎症,阿尔茨海默氏症风险,社会决定因素和表观遗传衰老之间的联系.
- 关于脑脊液,多药,特萨莫雷林和特尔米沙坦的新治疗数据.
结论:
- 艾滋病毒的神经精神疾病并发症是多因素的,受病毒持久性,衰老和外部因素的影响.
- 需要进一步的研究来阐明病变发生和开发针对神经HIV的向疗法.
相关概念视频
Retrovirus Life Cycles
45.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.3K
Psychosis and Antipsychotic Drugs: Overview
151
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
151
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303
Drugs Affecting Neurotransmitter Release or Uptake
843
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
843
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Psychoneuroimmunology: Diabetes and Cancer
14
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
14

